Desensitization to natalizumab: clinical and immunological observations

Mult Scler. 2013 Mar;19(3):376-7. doi: 10.1177/1352458512448269. Epub 2012 May 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / adverse effects*
  • Desensitization, Immunologic / methods*
  • Drug Hypersensitivity / drug therapy*
  • Female
  • Humans
  • Immune Tolerance*
  • Immunologic Factors / administration & dosage*
  • Immunologic Factors / adverse effects*
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Immunologic Factors